Related Experiment Video
Updated: Jun 26, 2026
05:30
Laparoscopic Radical Gastrectomy for Remnant Gastric Cancer
Published on: October 31, 2025
Pediatric gastric lymphoma: a rare entity
Caroline Jacquemart1, Ornella Guidi, Isabelle Etienne
1Hémato-oncologie pédiatrique, CHR Citadelle-Liège-Belgique, Belgium.
Journal of Pediatric Hematology/Oncology
|January 10, 2009
Summary
Pediatric gastric Burkitt-like lymphoma is rare. This case details a 13-year-old boy successfully treated with chemotherapy alone for localized gastric lymphoma, achieving complete remission.
Area of Science:
- Pediatric Oncology
- Gastroenterology
- Hematology
Background:
- Primary gastric lymphoma is uncommon in children.
- Burkitt-like lymphoma can present with non-specific gastrointestinal symptoms.
Observation:
- A 13-year-old male presented with symptoms mimicking gastritis, including epigastric pain, anemia, anorexia, and weight loss.
- Diagnostic workup revealed a localized gastric Burkitt-like lymphoma without Helicobacter pylori infection.
- Imaging with F-fluorodeoxyglucose-positron emission tomography showed a hypermetabolic gastric mass.
Findings:
- Biopsies confirmed the diagnosis of gastric Burkitt-like lymphoma.
- The patient was treated with chemotherapy according to the FAB/LMB 96 trial.
- Achieved first complete remission 2.5 years post-diagnosis.
Implications:
- This case highlights the importance of considering rare diagnoses in pediatric gastrointestinal symptoms.
- Chemotherapy alone can be effective for localized gastric Burkitt-like lymphoma in children.
- Successful treatment outcomes are achievable with current therapeutic protocols.
Related Concept Videos
01:23Pharmacokinetics in Pediatric Patients: Overview and Drug Absorption
Understanding the physiological differences in the pediatric population is crucial for effective pharmacotherapy. Neonates, infants, and children exhibit significant variations in gastric pH, gastric emptying time, intestinal transit time, and biliary function. These variations profoundly affect oral drug absorption, necessitating a nuanced approach to pediatric dosing.Neonates present with a unique physiological profile, having a gastric pH greater than 4 and faster and more irregular gastric...
01:11Pyloric Obstruction
Pyloric obstruction, also referred to as gastric outlet obstruction, is a condition characterized by narrowing or blockage at the pylorus—the muscular valve regulating the flow of stomach contents into the duodenum. When this passage becomes impaired, the stomach cannot effectively empty its contents into the small intestine. This disruption leads to a range of gastrointestinal symptoms, including early satiety, bloating, epigastric pain, postprandial nausea, persistent vomiting, and...
01:17Pharmacokinetics in Pediatric Patients: Drug Distribution
Drug distribution in the pediatric population exhibits unique challenges and considerations due to the physiological differences between children, particularly neonates and infants, and adults. A crucial aspect of pediatric pharmacology is understanding how these differences impact the pharmacokinetics of various drugs, necessitating age-specific dosing strategies to ensure efficacy and safety.Neonates and infants have a higher total body water content, ~75%–90% of their body weight, compared...